0.00Open0.02Pre Close0 Volume165 Open Interest815.00Strike Price0.00Turnover1175.15%IV6.52%PremiumJan 3, 2025Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.02Extrinsic Value100Contract SizeAmericanOptions Type0.0051Delta0.0012Gamma38255.00Leverage Ratio-115.7917Theta0.0000Rho193.30Eff Leverage0.0002Vega
Eli Lilly and Co Stock Discussion
US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website
$Eli Lilly and Co (LLY.US)$
$Eli Lilly and Co (LLY.US)$
No comment yet